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Lupus nephritis is associated with thickening of the
glomerular basement membrane. Here we measured
expression of proteins involved in extracellular matrix
turnover in kidneys of lupus-prone mice of the NZBxNZW F1
(B/W) strain before the onset of the disease until the
development of proteinuria. Expression of the major isoforms
of glomerular basement collagen IV (a3/a4/a5) was
unchanged throughout disease progression. Collagen IV a1
and a2, however, were highly upregulated at the proteinuric
stage while collagen IV a6 was increased at all time points
compared to normal mice. There was increased expression of
matrix metalloproteinase-2 and -9, their protein inhibitors
TIMP-1 and -2 and the metalloproteinase-9 stabilizing protein
lipocalin-2 in kidneys of nephritic lupus-prone mice. When
proteinuria appeared we found an increased net glomerular
gelatinolytic activity. These studies suggest that matrix
metalloproteinases contribute to extracellular matrix
expansion and proteinuria by altering matrix composition.
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Systemic lupus erythematosus is a systemic autoimmune
disease characterized by chronic inflammatory processes
associated with deposition of immune complexes in different
organs. The glomerulus is one of the sites most seriously
affected, with tissue damage progressing to end-stage renal
disease in as much as 30% of patients. Although various
functional disturbances within tissues have been implicated
in the pathogenesis of systemic lupus erythematosus, details
of the initiating events and accompanying detrimental
processes on both systemic and end-organ levels remain
largely unknown.
The histological presentation and patterns of glomerular
injury in lupus nephritis are heterogeneous, with varying
involvement of mesangial and vascular elements. An
invariant finding, however, is the accumulation of immune
complexes within glomerular membranes, which is often
accompanied by an apparent expansion of vascular and/or
mesangial extracellular matrices as the disease progresses.
The causes underlying the observed glomerular basement
membrane (GBM) thickening are unknown, but it has
been speculated that increased synthesis or decreased turn-
over of extracellular matrix constituents such as collagen IV
might be contributing factors.1–3 On the basis of gene
expression and immunohistochemical data, previous
studies have reported increases in collagen IV in mice with
chronic graft-versus-host disease—another model of lupus
nephritis.4,5
Autoantibodies against dsDNA are considered to be an
important factor in the evolution of lupus nephritis. Several
nephritogenic anti-dsDNA antibodies appear to bind DNA in
the form of nucleosomes, and extracellular chromatin has
been found to colocalize with such antibodies in situ.6,7
Recent data from our group demonstrated considerable
affinity of nucleosomes for collagen IV.8 Within this context,
increased production or reduced degradation of collagen IV
might theoretically contribute to accumulation of extracel-
lular chromatin, thus maintaining or aggravating autoanti-
body deposition. We therefore aimed to look at the changes
occurring in extracellular matrix composition and turnover
around the time of appearance of glomerular immune
complexes and the onset of nephritis.
Matrix metalloproteinases (MMPs) represent a family of
endopeptidases that play a key role in the turnover
of extracellular matrix proteins, and altered expression of
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MMPs is believed to be involved in the development of
several glomerulopathies.9,10 MMP-2 and MMP-9, referred to
as the gelatinases, have collagen IV among their main
substrates, and increased gene expression of these particular
MMPs has been especially implicated in glomerulonephritis,
including both human10 and murine11 lupus nephritis.
However, natural inhibitors of MMP activity, the tissue
inhibitors of metalloproteinases (TIMPs), are also differen-
tially expressed in nephritis,12–14 complicating the interpreta-
tion of net effects on in vivo proteolytic activity.
We have followed the time course of the development of
nephritis in a mouse model of lupus nephritis, NZBxNZW F1
(B/W) mice, analyzing gene expression patterns for collagen IV,
MMP-2, MMP-9, and TIMP 1–4 within the kidneys at
prenephritic stages and at the onset of proteinuria. On the basis
of findings of altered levels of expression of MMP-2, MMP-9,
TIMP-1, and TIMP-2, we examined the net effect in vivo on
renal gelatinolytic activity utilizing an in situ zymography assay.
RESULTS
The B/W mouse is an extensively studied model of systemic
lupus erythematosus,15 and mice of this breed develop anti-
dsDNA antibodies from a relatively early age.16 We detected
no anti-dsDNA antibodies in serum from young B/W mice or
BALB/c controls. Moderate increase in the titer was first
observed in the 20-week-old (w.o.) B/W, with a further
increase toward development of proteinuria (Figure 1a).
Transmission electron microscopy (TEM) analysis of B/W
glomeruli revealed normal membranes in 4 and 8 w.o. mice
(Figure 1b and c). Whereas only focal membrane irregula-
rities were found in the 20 w.o. B/W mice (Figure 1d),
dramatic changes involving thickening of capillary mem-
branes and mesangial matrix along with the presence of
electron-dense structures and fused podocyte processes were
seen in the proteinuric animals (Figure 1e). These electron-
dense structures, typical of lupus nephritis, have been shown
to colocalize with autoantibody deposits.7,17
Alterations in ECM composition during development of
nephritis
Kidney morphology was examined at the age of 4, 8, and 20
weeks as well as at the onset of proteinuria in both B/W and
age-matched BALB/c controls. There was no significant
matrix expansion in young, nonproteinuric mice as deter-
mined by hematoxylin and eosin or periodic acid schiff (PAS)
staining (Figure 2a), whereas mild expansion and increased
cellularity was seen in the 20 w.o. B/W mice (Figure 2b). At
the onset of proteinuria, the animals showed significant
expansion of the mesangial matrix and disruption of
glomerular architecture (Figure 2c). No such changes were
found in the age-matched BALB/c controls (Figure 2d).
Immunofluorescence staining against collagen IV reveals
expansion of perivascular and mesangial collagen matrix at
proteinuria compared with prenephritic mice (Figure 2e
and f), consistent with histological and TEM findings of
matrix expansion.
The main collagen IV isoform present in the GBM consists
of trimers of chains a3-a5, organized into a3/a4/a5(IV)
heteropolymeric fibers.18 mRNA expression of collagen IV a4
remained relatively stable through all the observed time
points in both B/W and BALB/c kidneys (Figure 2g). Similar
trends were seen for collagen IV a3 and a5 (data not shown).
At the same time, expression of the remaining collagen IV
chains, a1, a2, and a6, was significantly altered in the lupus
prone mice. There was an age-related downregulation of
collagen IV a1 and a2 mRNA levels in the BALB/c mice. In
the B/W mice, collagen IV a1 and a2 mRNA levels followed
the same pattern up to 20 weeks of age but then became
significantly upregulated at the proteinuric stage compared
with the 20 w.o. group (Figure 2h and i, Po0.05). Expression
of collagen IV a6 was much higher in the B/W mice
compared with their BALB/c counterparts at all time points
studied (Figure 2j, Po0.01). mRNA expression of the
collagen chains was also examined on microdissected
glomeruli from prenephritic and nephritic mice, confirming
that the alterations in collagen IV expression are of
glomerular origin (Figure 2g–j, insets).
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Figure 1 | Serum anti-dsDNA autoantibodies and TEM of
(NZBxNZW)F1 kidneys. (a) Antibodies against calf thymus
dsDNA in sera of B/W and BALB/c mice were detected at end
point by ELISA. Data are presented as mean±s.e.m., n¼ 5. (b and
c) TEM analysis revealed no major alterations in the capillary
membranes in the (b) 4 and (c) 8 w.o. B/W mice. (d) Focal irregular
membrane changes (*) were seen in 20 w.o. B/W. (e) Proteinuric
B/W showed dramatic thickening of capillary membranes (GBM)
with fused processes of epithelial cells (EpC) and electron dense
structures.
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Gene expression profiles of MMP-2, MMP-9, and TIMP 1–4
Next, we proceeded with analyses of gene expression of
proteins involved in matrix degradation, focusing on MMP-2
and MMP-9, which are major contributors to collagen IV
degradation. In contrast to stable, low-level expression of
MMP-2 in BALB/c kidneys and young B/W, expression was
increased more than 100-fold in three of five of the
proteinuric B/W mice, whereas the remaining two showed
doubling of expression levels compared with 20 w.o. B/W
mice (Figure 3a). Whereas the expression of MMP-9 in
normal mice decreased with age, a different trend was
observed in the B/W, with a twofold upregulation in the
proteinuric group compared with the age-matched BALB/c
(Figure 3b, Po0.05). Recent studies have shown the 25 kDa
protein lipocalin-2 (neutrophil gelatinase-associated lipo-
calin) to be a stabilizer of MMP-9 activity by preventing its
degradation.19 To evaluate possible contribution of lipocalin-
2 to the renal damage in B/W mice, the expression level of
lipocalin-2 was also determined. The proteinuric B/W
showed a profound increase in lipocalin-2 expression,
whereas stable, negligible mRNA levels were seen in BALB/c
of all ages and younger B/W (Figure 3c, Po0.01).
Tissue inhibitors of metalloproteinases are the major
negative modulators of MMP activity in vivo, and the
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Figure 2 | Hematoxylin and eosin and PAS staining, immunofluorescent detection of collagen IV and type IV procollagen a1, 2, 4,
and 6 mRNA expression in kidneys of B/W and BALB/c mice of different ages. (a–e) Histological staining was done on 4-mm-thick
sections of paraffin-embedded tissue. B/W mouse at (a) 8 and (b) 20 weeks of age and (c) at the onset of proteinuria (30.6±4 weeks);
(d) BALB/c mouse at 31 weeks of age. Immunofluorescent staining for type IV collagen was performed on cryosections from 20 (e) w.o. and
(f) proteinuric B/W kidneys. Real-time PCR for type IV procollagens (g) a4, (h) a1, (i) a2, and (j) a6 was performed with TaqMan Gene
Expression Assays. TATA-box binding protein expression was used to normalize the results. The data are presented as fold-change relative
to four w.o. BALB/c (DDCt calculations). Insets show expression for RNA isolated from microdissected glomeruli and tubuli of proteinuric
B/W relative to glomeruli from 20 w.o. B/W mice. Data are presented as mean±s.e.m., n¼ 5.
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coordinated regulation of MMPs and TIMPs is a prerequisite
for the maintenance of appropriate extracellular matrix
(ECM) turnover. mRNA expression of TIMP-1 and TIMP-2
was upregulated in the proteinuric B/W in comparison with
the stable, low-level expression in the younger B/W and in the
age-matched BALB/c (Figure 3d and e, Po0.05). There was a
considerable variation in TIMP-1 levels within the protei-
nuric group that paralleled changes in MMP-2 expression,
indicating that regulation of TIMP-1 and MMP-2 expression
are closely interrelated. No correlation could be found
between MMP-2 mRNA levels and age at development of
proteinuria or anti-dsDNA titer. TIMP-3 expression did not
differ significantly between the strains or the age groups
studied (Figure 3f).
To verify that the alterations in gene expression are of
glomerular origin, quantitative real-time PCR was also
performed on RNA isolated from microdissected glomeruli
from 20 w.o. and proteinuric B/W, and gave corresponding
results (Figure 3a, b, d, e, insets).
Localization of MMP-2, MMP-9, lipocalin-2, TIMP-1, and
TIMP-2 by immunofluorescence
Immunofluorescence analysis of MMPs and TIMPs localiza-
tion revealed a significant increase in MMP-2 staining within
the glomeruli of B/W mice between 20 weeks of age and the
onset of proteinuria (Figure 4a and b). The distribution of
MMP-2 appeared relatively uniform throughout the mesan-
gium in the 20 w.o. group, spreading into the capillary
membranes upon development of proteinuria.
Matrix metalloproteinase-9 staining showed similar
distribution, and was also significantly more intense in the
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Figure 3 | Real-time PCR analysis of MMP/TIMP expression.
Fold-change of mRNA expression for (a) MMP-2, (b) MMP-9,
(c) lipocalin-2, and (d) TIMP-1, (e) TIMP-2 and (f) TIMP-3 relative to
four w.o. BALB/c as determined by DDCt calculations. Insets show
expression for RNA isolated from microdissected glomeruli and
tubuli of proteinuric B/W relative to glomeruli from 20 w.o. B/W
mice. Data are presented as mean±s.e.m., n¼ 5.
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Figure 4 | Immunofluorescence for MMP/TIMP expression on
B/W and BALB/c kidney sections (4 lm cryostat sections,
 600 original magnification). Identical exposure settings were
used for slides stained with the same antibodies. (a and b) MMP-2
staining in glomeruli from (a) 20 w.o. and (b) proteinuric B/W.
(c and d) MMP-9 staining in 20 (c) w.o. and (d) proteinuric B/W.
(e–h) Glomeruli from proteinuric B/W stained with antibodies
against (e) lipocalin-2, (f) TIMP-1, (g) TIMP-2 or with normal rabbit
serum IgG, used as a (h) negative control.
Kidney International (2008) 74, 1150–1158 1153
AA Tveita et al.: MMPs in lupus nephritis o r i g i n a l a r t i c l e
proteinuric than in the younger mice (Figure 4c and d).
Antibodies against lipocalin-2 gave strong staining within the
glomerular space of proteinuric B/W (Figure 4e), whereas
tubular staining was weaker and more scattered (data not
shown).
For TIMP-1, no staining could be detected in the younger
B/W mice, whereas clearly positive fluorescent signal was
detected predominately in the mesangium in the proteinuric
animals (Figure 4f). TIMP-2 was distributed throughout the
glomerular space, with scattered, weaker tubular signals,
mainly in the periglomerular tubuli in the proteinuric mice
(Figure 4g). No staining could be detected when normal
rabbit IgG substituted for primary antibody (Figure 4h).
In situ zymography
Using a fluorescently labeled gelatin substrate, kidney
sections were assayed for total gelatinolytic activity. BALB/c
kidneys showed low level of gelatinolysis irrespective of age
(Figure 5a and b), and similar signal intensity was also
detected on the sections from 4 w.o. (data not shown), 8 w.o.
(Figure 5c), and 20 w.o. (Figure 5d) B/W mice. Compared
with both younger B/W and age-matched BALB/c, there was
a dramatic increase in gelatinolytic activity in the glomeruli
of proteinuric mice (Figure 5e). No such changes were
apparent within the peritubular space. Addition of the broad-
spectrum MMP inhibitor ethylenediaminetetraacetic acid
(EDTA) (10 mM) to the reaction mixture was used to verify
the contribution of MMPs to gelatinolysis in the nephritic
B/W kidneys (Figure 5f).
Gel zymography, immunoprecipitation and western blot
analysis
To further characterize the observed gelatinolytic activity,
cortical tissue homogenates were analyzed by gelatin
zymography (Figure 5g). There was evidence of increased
enzymatic activity of pro-MMP-2 (72 kDa) in homogenates
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Figure 5 | Characterization of renal gelatinase activity. (a–f) In situ zymography with a gelatin substrate on sections of kidney shows a
considerable increase in gelatinolytic activity within the glomeruli in (e) the proteinuric B/W mice compared with (a) young and
(b) age-matched BALB/c and younger B/W of ages (c) 8 and (d) 20 weeks. Little activity is detected in the peritubular space in any of the
sections. (f) The inclusion of 10 mM EDTA in the gelatin substrate dramatically reduces gelatinolytic activity in the nephritic kidney sections,
confirming MMPs as the main contributors to the observed increase in proteolysis. (g) Gel zymography of kidney cortex homogenates from
B/W and BALB/c reveals the presence of gelatinolytic activity corresponding to MMP-9 (105 kDa) and MMP-2 (72 kDa). Lane 1 contains
purified pro-forms of human MMP-2 and MMP-9. Lanes 2–6 show BALB/c of 8 (lane 2) and 28 (lane 3) weeks of age, and B/W of 8 (lane 4),
20 (lane 5), and 28 (proteinuric stage; lane 6) weeks of age. (h) Western blot shows staining for MMP-9 on kidney homogenates from
20 w.o. (lane 1) and proteinuric (lanes 2–3) B/W mice. (i) Immunoprecipitation of kidney homogenates from nephritic B/W with antibodies
against lipocalin-2 (lane 2) or MMP-9 (lane 3), visualized by Coomassie staining after elution and nonreducing SDS-PAGE. Lanes 4 and 5
show western blot where precipitates of lipocalin-2 and MMP-9 were probed with anti-MMP-9 (lane 4) and anti-lipocalin-2 (lane 5) antibody,
respectively, to confirm co-immunoprecipitation of MMP-9/lipocalin-2 complex (125 kDa). The identity of the smaller band in lane 2 is
unknown, whereas the smaller band visible in lane 3 likely represents monomeric MMP-9 (105/95 kDa). Lane 1 contains MagicMark XP
protein size markers (Invitrogen).
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from 20 w.o. and nephritic B/W (Figure 5g, lanes 5–6)
compared with normal BALB/c (lanes 2–3) and younger B/W
(lane 4). Bands corresponding to pro-form of MMP-9
(105 kDa) were much stronger in 20 w.o. and proteinuric
B/W (lanes 5–6) than in the younger mice (lane 4), and a
weaker band with slightly faster migration representing active
MMP-9 was seen exclusively in the 20 w.o. (lane 5) and
proteinuric B/W (lane 6) mice. An area of strong gelatinolytic
activity was also seen in the higher molecular weight region
in all the lanes, and was weakened in the presence of EDTA
but not Pefabloc, suggesting that higher molecular weight
MMP complexes account for much of this activity (data not
shown).
Western blot analysis confirmed the identity of gelatino-
lytic bands of the zymogram as those of MMP-2 (data not
shown) and MMP-9 (Figure 5h). For MMP-9, a high
molecular weight band (B180 kDa), smaller than the
expected size of an MMP-9 homodimer (220 kDa), was
apparent on western blot from 20 w.o. (Figure 5h, lane 1) and
proteinuric B/W (lanes 2–3), and this could account for some
of the high molecular weight smear visible in the zymography
gel. The band in the B125 kDa region (Figure 5h, lanes 1–3)
was also reactive against lipocalin-2 when reprobing was
done with the antibodies against lipocalin-2 (data not
shown), suggesting that this band represents a neutrophil
gelatinase-associated lipocalin/MMP-9 complex. No band
could be visualized for free MMP-9 (105 kDa).
Immunoprecipitation of kidney homogenate from protei-
nuric B/W with antibodies against either lipocalin-2 (Figure
5i, lane 2) or MMP-9 (lane 3) produced bands of identical
size at about 125 kDa, corresponding to the expected size of
an MMP-9/lipocalin-2 complex,19 when visualized by Coo-
massie staining after nonreducing SDS–polyacrylamide gel
electrophoresis (SDS-PAGE). The intensity of this band was
higher than for the band corresponding to the monomeric
form of MMP-9 (lane 3), indicating that the molecules are
largely found in vivo in the form of a complex. The identities
of the immunoprecipitated bands were confirmed by western
blot analysis, showing immunoreactivity of lipocalin-2
immunoprecipitated protein with antibodies against MMP-
9 (lane 4) and vice versa (lane 5).
DISCUSSION
Glomerular basement membrane thickening and mesangial
matrix expansion are significant morphological changes in
lupus nephritis. Our data show that gene expression for the
collagen IV isoform most abundant in the GBM (a3/a4/a5)
remains relatively stable during the development of nephritis.
At the same time, collagen IV a1 and a2 were increased at the
onset of proteinuria. Also, the collagen IV a6 chain, normally
found only in the parietal layer of Bowman’s capsule, was
upregulated in B/W at all time points, being particularly high
at the proteinuric stage. Although we cannot at present
exclude the possibility that changes in collagen IV a6
expression are unrelated to the development of nephritis,
quantitative reverse transcription-PCR assays on kidneys
from normal C57Bl/6 mice show an expression profile for
collagen IV a6 similar to that of BALB/c (A. Tveita,
unpublished data). Interestingly, there is a number of well-
known hereditary glomerulopathies associated with deposi-
tion of aberrant collagen IV networks, including Alport
syndrome and thin basement membrane nephropathy, where
switches in collagen IV isoforms expression toward a1/a2 are
seen in the GBM.20,21 The presence of the a3/a4/a5 network
has been shown to be important for the stability and proper
functioning of the GBM, and its replacement by an a1/a2
network could lead to a nonfunctional glomerular filter.22
Our data suggest that such a collagen IV isoform switch
could occur around the time of onset of proteinuria. The
relevance of these findings is a focus of ongoing investigations
in our group.
Here, we present evidence for increased MMP-2 and
MMP-9 expression and activity within the glomerular
mesangial space coinciding with the appearance of morpho-
logical evidence of ECM expansion and the development of
proteinuria in lupus-prone B/W mice. Data from gel
zymography and immunofluorescence studies demonstrate
MMP-9 as the main contributor to the increased gelatinolytic
activity. This is in accordance with findings in several other
models of glomerulonephritis.10,23 Interestingly, in our study,
increase in MMP-9 gene expression at the onset of
proteinuria is not as pronounced as for MMP-2. This
suggests that some post-transcriptional mechanism is active
in maintaining a high level of MMP-9 activity. Lipocalin-2 is
a secreted protein that covalently binds to MMP-9 and
protects it from autolysis.19 In addition to its constitutive
expression in neutrophils, lipocalin-2 is induced in a variety
of epithelial cells in inflammatory conditions.24 We find that
lipocalin-2 gene expression is highly upregulated in the
proteinuric B/W, and strong immunofluorescent staining for
lipocalin-2 is present in glomeruli of proteinuric B/W. Also,
zymography showed increased gelatinolytic activity corre-
sponding to a neutrophil gelatinase-associated lipocalin/
MMP-9 complex. Stabilization by lipocalin-2 could thus
explain the seemingly paradoxical findings of relatively stable
MMP-9 gene expression and the increased contribution of
MMP-9 to gelatinolytic activity in proteinuric B/W. More-
over, it was recently reported that urinary levels of lipocalin-2
correlated positively with renal disease activity in human
systemic lupus erythematosus, and it has been proposed as a
valuable early marker of the disease.25
Accumulation of extracellular chromatin and the
formation/deposition of immune complexes are observed
by TEM as glomerular matrix-associated electron-dense
structures in prenephritic stages of lupus nephritis develop-
ment.17,26 By causing alterations in the composition or
integrity of the membranes, increased MMP activity could
potentially contribute to such a process, and this may be
important in the initiation and/or maintenance of immune
complex depositions. Additionally, immune complexes might
be directly involved in the induction of increased MMP
expression.27,28 In this manner, one could envision a synergic
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amplification of glomerular damage with increased proteo-
lysis facilitating immune complex deposition. A recent study
of the influence of anti-dsDNA autoantibodies on gene
expression in isolated mesangial cells showed strong increase
in lipocalin-2 production induced by several nephritogenic
antibodies.29 This could provide a direct link between
autoantibody-induced signaling and the increase in gelati-
nolytic activity seen in our study.
Tissue inhibitors of metalloproteinase-1 expression level
correlated strongly with the increase in MMP-2 expression at
the proteinuric time point, which suggests a compensatory
regulatory coupling between these antagonistic components.
Interpreting MMP/TIMP balance in the context of ECM
turnover alone is likely an oversimplification considering
recent findings of the effects of both MMPs and TIMPs on a
wide variety of cellular processes, including growth cycle
progression, cellular proliferation, and apoptosis.30–33 More
studies are needed to clarify the consequences of altered
TIMP and MMP expression in lupus nephritis.
In summary, the net gelatinolytic activity within the
glomeruli is significantly upregulated in murine lupus
nephritis, and MMP-9 appears as the main contributor.
Concomitantly, TIMP expression is increased, possibly
through compensatory processes, but does not prevent the
observed increase in gelatinolysis. Synthesis of normal GBM
collagen IV isoform a3/a4/a5 appears relatively unchanged
during the development of nephritis. The apparent expansion
of glomerular membranes seen in the course of the disease
could be due to qualitative alterations in the matrix structure,
similarly to what has been proposed to occur in other types
of nephropathies,34,35 with MMPs conceivably contributing
by distorting matrix organization and causing changes that
favor deposition of immune complexes within the mem-
branes.
Understanding the pathophysiological consequences of
altered MMP activity and alterations in membrane composi-
tion within the glomerulus might help to shed light on
pathways involved in the development of lupus nephritis and
could prove valuable in devising new therapeutic strategies.
MATERIALS AND METHODS
Mice and tissue samples
Female BALB/c and B/W mice were purchased from Harlan (Black-
thorn, UK). All experiments were approved by Norwegian Ethical and
Welfare Board for Research Animals. Proteinuria in B/W mice was
monitored weekly with sticks (Bayer Diagnostics, Bridgend, UK).
Animals were euthanized by CO2 suffocation at the age of 4, 8, and 20
weeks (Groups 1, 2, and 3, respectively) or upon development of
proteinuria (43 g/l) (Group 4: X26 w.o. mice). Terminal blood
samples collected from heart were used to prepare serum and stored at
20 1C. Kidneys were extirpated, cut, and preserved in RNAlater
(Ambion Inc., TX, USA), fixed in 4% paraformaldehyde or
McDowell’s fixative for morphological studies by electron micro-
scopy,17 snap-frozen in liquid N2 for protein extraction, or embedded
in optimal cutting temperature compound and frozen in liquid N2 for
immunofluorescent microscopy. The same samples were obtained
from gender- and age-matched BALB/c control mice.
Anti-dsDNA ELISA
Serum antibodies against calf thymus dsDNA were detected and
titrated by standard indirect ELISA, as described previously.36 The
murine monoclonal antibody 163p77, reactive with dsDNA and
nucleosomes, and anti-DNA antibody-negative BALB/c serum was
included as an intra-assay control.37
Transmission electron microscopy
For morphological studies by TEM, kidney tissue was treated
according to standard procedures.38 Micrographs were taken using a
Jeol Transmission Electron Microscope (Tokyo, Japan).
Laser capture microdissection
Ten-micrometer cryosections were prepared and immediately fixed
in zinc buffer (40 mM ZnCl2, 30 mM ZnAc2  2H2O and 600 mM
CaAc2 in 0.1 M Tris, pH 7.4) for 5 min, stained with hematoxylin,
dehydrated, air-dried, and overlaid with liquid coverglass (PALM-
Zeiss, Bernreid, Germany). Glomeruli and tubuli were collected by
laser capture microdissection on a PALM Laser-MicroBeam System.
For each sample, 120 glomeruli and a corresponding surface-area of
tubular tissue was collected, lyzed in Trizol (Invitrogen, Carlsbad,
CA, USA), and stored at 70 1C.
cDNA synthesis
Total RNA was isolated from RNAlater-preserved kidneys using
EZ-1 RNA tissue mini kit (Qiagen, Nordic, Norway). The concen-
tration of extracted RNA was determined spectrophotometrically
with NanoDrop (NanoDrop technologies, Wilmington, DE, USA)
and quality was assessed using Agilent Bioanalyzer (Agilent Techno-
logies, Santa Clara, CA, USA). Samples were reverse-transcribed
with random primers using High Capacity cDNA Reverse
Transcription kit (Applied Biosystems, Foster City, CA, USA). For
microdissected tissue, RNA was isolated by Trizol extraction on
Phase Lock Heavy gel (Eppendorf Nordic, Horsholm, Denmark).
Real-time PCR analysis
Quantitative PCR was performed on ABI Prism 7900HT Sequence
Detection System (Applied Biosystems) using predesigned TaqMan
Gene Expression Assays (Applied Biosystems; accession numbers in
the supplement). TATA box binding protein was used as an
endogenous control. Relative expression levels were calculated using
DDCt method.
Immunofluorescent microscopy
Four-micrometer-thick sections of optimal cutting temperature
compound-embedded kidneys were blocked for 1 h with 10% calf
serum and 1%BSA in phosphate-buffered saline (PBS) followed by
washing and 30 min incubation with primary antibody (details
in the supplement). Slides were washed and incubated for 30 min
with Alexa-546-conjugated anti-rabbit F(ab)2 secondary antibody
(Invitrogen). Normal rabbit IgG was used as negative control.
In situ zymography
To detect the loci of ECM proteolytic activity within normal and
nephritic kidney sections, an in situ zymography approach was
employed.28 Briefly, 8-mm-thick optimal cutting temperature
compound-mounted kidney sections were washed in PBS and
incubated for 2 h in DQ-labeled gelatin (Invitrogen) substrate
solution (20 mg/ml DQ-gelatin, 50 mM Tris pH 6.8, 50 mM NaCl,
20 mM CaCl2) at 37 1C in the dark. To verify the contribution of
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MMPs, control slides were pre-incubated for 1 h with 10 mM EDTA,
a known inhibitor of gelatinase activity, and incubated in labeled
DQ-substrate solution containing 10 mM EDTA. Substrate solution
was washed off, slides were incubated in 4% formaldehyde for
10 min, washed with PBS, mounted with Glycergel mounting
medium (Dako, Glostrup, Denmark), and photographed with
identical exposure settings using a fluorescence microscope.
Gel zymography
Protein isolation was done as described previously.39 Briefly, snap-
frozen cortical tissue was homogenized in Tris buffer (0.5 mol/l Tris-
HCl, pH 7.5, 150 mmol/l NaCl) and centrifuged and the supernatant
was collected. Pellet was resuspended in heat extraction buffer
(50 mM Tris pH 7.5, 0.1 M CaCl2, 0.15 M NaCl), incubated for 4 min
at 60 1C, and centrifuged, and the supernatant was collected. The
supernatants were combined, and protein content was determined
using BCA assay kit (Pierce Biochemicals, IL, USA). The samples
were run on 7.5% SDS-PAGE containing gelatin (1.0 mg/ml)
without previous heating or reduction. Following electrophoresis,
gels were washed for 1 h in 2% Triton X-100 in 50 mM Tris-HCl, pH
7.4, followed by incubation at 37 1C for 20 h in activation buffer
(50 mM Tris-HCl, pH 7.4, 5 mM CaCl2). Gels were stained with
Coomassie Blue. Clear zones in the background demonstrate the
presence of protease activity. Control experiments were performed
in the presence of 15 mM MMP inhibitor EDTA and 2 mM serine
protease inhibitor Pefabloc SC (Fluka, Switzerland). The inhibitors
were added for all incubation steps after electrophoresis. Pro-MMP-
2 (MW 72 kDa), proMMP-9 (MW 92 kDa), and homodimeric
MMP-9 form (MW 225 kDa) from human fibroblast cell lines were
used as standards.
Immunoprecipitation
A total of 100 ml aliquots of aqueous suspension of protein A-
Sepharose 4B (Sigma-Aldrich, Basel, Switzerland) were washed in
cold PBS, mixed with 5 mg of polyclonal rabbit anti-mouse MMP-9
or anti-lipocalin-2 antibody, shaken for 35 min, and centrifuged.
The pellet was incubated with 200 ml aliquots of kidney homogenate
from nephritic B/W and incubated overnight at 4 1C. After
centrifugation, pellets were washed extensively with ice-cold PBS,
centrifuged, and resuspended in 50ml of elution buffer (0.1 M
glycine-HCl, pH 2.5); pH was subsequently adjusted by the addition
of 5 ml of 1 M Tris pH 7.5. Aliquots of the immunoprecipitated
proteins were heated to 95 1C for 3 min resolved by nonreducing
SDS-PAGE and evaluated by Coomassie staining and western blot.
Western blot analysis
SDS–polyacrylamide gel electrophoresis and western blotting were
performed according to standard procedures. Membranes were
blocked with 5% (w/v) skimmed milk for 1 h before application
of primary antibody overnight at 4 1C. Binding was revealed by
chemiluminescence detection. Determination of molecular weight
was done by comparison with MagicMark XP molecular weight
markers (Invitrogen).
Statistics
The results are presented as mean±s.e.m. Comparison between
groups was performed by two-way analysis of variance. Po0.05 was
considered statistically significant.
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